marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Sonoma Pharmaceuticals Financial Ratios 2011-2024 | SNOA
Annual Financial Ratios Sonoma Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.3 | -0.8 | -0.0 | -2.0 | -2.5 | -0.6 | -1.2 | 3.1 | -1.6 | -0.9 | 5.5 | -4.8 | -3.8 | -6.4 |
P/S |
0.1 | 0.3 | 0.0 | 0.4 | 0.4 | 0.4 | 1.0 | 2.3 | 1.1 | 0.5 | 1.5 | 1.7 | 2.2 | 5.2 |
EPS |
-0.5 | -1.5 | -1.9 | -2.0 | -2.2 | -12.8 | -28.5 | 2.2 | -3.1 | -0.8 | 0.5 | -1.3 | -1.9 | -0.3 |
EV (Enterprise Value) |
7.11 M | 8.37 M | 2.76 M | 13.4 M | 9.67 M | 7.59 M | 11 M | 15.5 M | 12.5 M | 4.29 M | 23.8 M | 26.8 M | 33.6 M | 53.8 M |
EBITDA per Share |
-0.5 | -1.31 | -2.15 K | -1.61 | -4.31 | -11.7 | -27.2 | -26.8 | -27.1 | -29.9 | -37.7 | -28.1 | -70.6 | -84.9 |
EV/EBITDA |
-4.2 | -0.7 | -0.4 | -0.5 | -0.9 | -0.9 | -0.2 | -2.6 | -6.5 | -4.6 | -6.9 | |||
PEG |
-0.0 | -0.0 | -0.0 | 0.06 | -0.03 | -0.01 | 0.0 | 0.02 | -0.06 | 0.0 | 0.04 | -0.15 | -0.38 | -0.39 |
P/B |
0.3 | 0.5 | 0.0 | 1.5 | 0.9 | 0.7 | 1.1 | 1.4 | 1.6 | 0.6 | 1.7 | 6.4 | -32.5 | 30.1 |
P/CF |
-0.7 | -0.6 | -0.0 | -2.4 | -1.6 | -0.6 | -1.4 | -3.4 | -1.8 | -1.1 | -3.8 | 29.3 | -6.5 | -11.1 |
ROE % |
-78.78 | -64.57 | -58.48 | -73.65 | -33.84 | -112.48 | -93.49 | 43.27 | -100.22 | -68.05 | 30.96 | -133.08 | 844.35 | -467.25 |
ROA % |
-32.80 | -31.74 | -26.99 | -26.36 | -20.23 | -81.66 | -74.60 | 36.43 | -73.62 | -54.51 | 17.96 | -43.22 | -93.51 | -91.74 |
ROCE % |
-76.60 | -57.29 | -67.69 | -64.31 | -68.80 | -103.69 | -88.99 | -58.52 | -99.02 | -53.41 | -45.78 | -45.36 | -209.36 | -176.63 |
Current Ratio |
1.7 | 2.0 | 1.9 | 1.6 | 2.5 | 3.5 | 5.0 | 6.9 | 3.6 | 3.7 | 1.3 | 2.2 | 1.5 | 1.8 |
DSO |
78.4 | 68.5 | 75.3 | 67.3 | 103.5 | 85.5 | 33.7 | 60.0 | 55.0 | 40.0 | 62.1 | 40.3 | 61.8 | 78.4 |
DIO |
127.4 | 114.6 | 109.8 | 71.4 | 75.5 | 123.3 | 111.9 | 113.3 | 76.0 | 77.9 | 75.3 | 76.9 | 86.3 | 74.1 |
DPO |
33.1 | 51.5 | 72.1 | 58.3 | 71.8 | 45.4 | 49.7 | 64.0 | 62.0 | 51.8 | 51.0 | 62.6 | 73.9 | 67.6 |
Operating Cycle |
205.8 | 183.0 | 185.1 | 138.7 | 178.9 | 208.8 | 145.5 | 173.3 | 131.0 | 117.9 | 137.5 | 117.2 | 148.1 | 152.4 |
Cash Conversion Cycle |
172.7 | 131.5 | 113.0 | 80.4 | 107.1 | 163.4 | 95.9 | 109.3 | 69.1 | 66.1 | 86.5 | 54.6 | 74.2 | 84.8 |
All numbers in USD currency
Quarterly Financial Ratios Sonoma Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.59 | -0.07 | - | -0.08 | -5.75 | -0.29 | - | -0.62 | -0.33 | -0.29 | - | -0.31 | -0.85 | -0.54 | - | -0.32 | -0.32 | 0.06 | 0.13 | -0.72 | -0.92 | 0.54 | 0.54 | -0.26 | -1.2 | -0.99 | - | -0.73 | -0.67 | -0.82 | - | 3.84 | 2.79 | -1.08 | - | -0.96 | -2.27 | -1.3 | - | -0.69 | -0.79 | -0.09 | - | -0.09 | -0.56 | -0.47 | - | -0.37 | -0.85 | -0.47 | - | -0.09 | -0.21 | -0.11 | - |
EBITDA per Share |
- | -0.07 | - | - | - | -0.24 | - | -0.59 | -206 | -266 | - | -311 | -1.07 K | -797 | - | -67.2 | 0.02 | 0.14 | -0.33 | -0.74 | -0.58 | -0.8 | -1.26 | -2.42 | -0.23 | -3.48 | - | -0.73 | -0.66 | -0.76 | - | -0.84 | -2.35 | -1.52 | - | -1.27 | -3.42 | -1.29 | - | -0.23 | -0.57 | -0.35 | - | -227 | -558 | -341 | - | -0.13 | -0.38 | -256 | - | -0.09 | -177 | -92.7 | - |
ROE % |
-60.25 | -75.01 | -58.67 | -93.55 | -115.49 | -103.83 | -60.51 | -68.96 | -42.53 | -46.74 | -50.90 | -74.67 | -71.49 | -58.08 | -33.28 | -7.27 | -11.66 | -16.05 | -28.80 | -24.84 | -32.39 | -39.95 | -54.38 | -82.96 | -88.08 | -88.62 | -58.97 | 12.01 | 105.34 | 317.01 | 206.60 | 172.07 | 66.55 | -194.83 | -138.85 | -214.40 | -255.41 | -238.07 | -131.56 | -149.54 | -91.98 | -281.98 | -376.99 | -438.12 | -481.26 | 354.88 | 220.85 | -1341.73 | -2843.18 | 649.78 | 1747.58 | -1562.58 | 4088.97 | -778.81 | - |
ROA % |
-24.67 | -31.09 | -25.73 | -39.65 | -47.65 | -43.56 | -25.89 | -30.77 | -21.73 | -25.73 | -23.46 | -30.78 | -29.47 | -22.25 | -13.81 | -5.20 | -8.20 | -11.34 | -19.11 | -15.45 | -22.36 | -31.66 | -41.50 | -63.82 | -67.70 | -65.92 | -47.25 | 11.75 | 88.10 | 229.06 | 145.81 | 119.78 | 34.76 | -145.35 | -108.30 | -158.27 | -182.22 | -165.27 | -90.37 | -96.58 | -52.81 | -58.28 | -77.51 | -93.68 | -103.63 | -84.02 | -49.54 | -77.90 | -90.10 | -139.43 | -132.72 | -28.36 | -71.63 | -32.73 | - |
ROCE % |
-64.68 | -70.09 | -51.02 | -84.01 | -104.39 | -93.52 | -54.15 | -62.72 | -38.31 | -52.57 | -73.69 | -74.81 | -67.36 | -43.81 | -0.78 | -7.01 | -15.78 | -23.42 | -36.58 | -45.39 | -53.12 | -61.97 | -74.86 | -82.27 | -87.10 | -87.16 | -58.31 | -73.90 | -67.05 | -215.99 | -266.02 | -311.96 | -342.31 | -278.96 | -186.64 | -211.54 | -190.50 | -124.68 | -85.16 | -130.67 | -151.29 | -368.22 | -391.49 | -413.23 | -389.46 | 262.53 | -7.76 | -1451.93 | -2874.36 | 405.97 | 1549.53 | -1444.17 | 3677.94 | -684.24 | - |
Current Ratio |
1.6 | 1.6 | 1.7 | 1.8 | 1.7 | 1.8 | 2.0 | 1.7 | 1.9 | 1.9 | 1.9 | 2.4 | 2.4 | 1.5 | 1.6 | 3.1 | 2.8 | 2.4 | 2.6 | 3.1 | 2.8 | 3.1 | 3.6 | 4.6 | 4.0 | 4.2 | 5.0 | 4.5 | 5.0 | 5.9 | 6.3 | 5.9 | 2.9 | 3.2 | 3.8 | 4.1 | 4.8 | 4.6 | 5.0 | 3.0 | 3.7 | 3.1 | 2.4 | 1.5 | 1.2 | 1.3 | 1.5 | 1.4 | 1.0 | 1.0 | 0.9 | 1.0 | 1.0 | 1.0 | 1.2 |
DSO |
81.6 | 82.7 | - | 74.1 | 77.9 | 66.7 | - | 74.1 | 67.4 | 55.5 | - | 98.6 | 28.3 | 35.6 | - | 89.5 | 92.9 | 79.0 | 81.1 | 95.2 | 28.8 | 36.8 | - | 52.6 | 44.8 | 34.6 | - | 53.2 | 60.9 | 57.7 | - | 57.5 | 25.2 | 34.4 | - | 97.6 | 34.3 | 23.9 | - | 50.5 | 19.0 | 25.7 | - | 69.7 | 19.6 | 23.8 | - | 76.2 | 23.0 | 28.9 | - | 65.3 | 51.5 | 64.5 | - |
DIO |
113.0 | 117.7 | - | 148.7 | 137.4 | 114.7 | - | 126.8 | 147.8 | 106.4 | - | 144.0 | 36.2 | 49.6 | - | 103.3 | 122.5 | 117.1 | 91.2 | 112.9 | 117.1 | 115.6 | 128.9 | 115.7 | 104.1 | 99.3 | - | 97.8 | 91.8 | 101.3 | - | 114.4 | 36.6 | 47.9 | - | 73.9 | 28.0 | 34.7 | - | 75.5 | 25.3 | 36.2 | - | 66.2 | 19.1 | 32.2 | - | 75.8 | 21.7 | 2525.1 | - | 92.6 | 26.7 | 3410.5 | - |
DPO |
31.3 | 29.7 | - | 50.3 | 54.4 | 39.6 | - | 51.3 | 79.6 | 72.2 | - | 92.9 | 26.3 | 34.7 | - | 87.4 | 113.8 | 115.4 | 81.7 | 84.8 | 69.0 | 47.3 | 45.9 | 46.2 | 50.6 | 47.4 | - | 49.3 | 37.7 | 44.7 | - | 65.5 | 23.8 | 36.1 | - | 59.1 | 21.1 | 25.8 | - | 58.2 | 19.9 | 25.4 | - | 102.7 | 25.0 | 32.7 | - | 54.9 | 18.9 | 2150.1 | - | 72.2 | 22.5 | 3310.1 | - |
Operating Cycle |
194.7 | 200.3 | - | 222.8 | 215.3 | 181.4 | - | 201.0 | 215.2 | 161.9 | - | 242.5 | 64.5 | 85.3 | - | 192.9 | 215.4 | 196.2 | 172.2 | 208.1 | 145.8 | 152.4 | 128.9 | 168.3 | 148.9 | 133.9 | - | 150.9 | 152.7 | 158.9 | - | 171.9 | 61.8 | 82.3 | - | 171.5 | 62.3 | 58.6 | - | 126.1 | 44.3 | 61.9 | - | 135.9 | 38.6 | 56.1 | - | 152.0 | 44.7 | 2553.9 | - | 157.9 | 78.3 | 3475.0 | - |
Cash Conversion Cycle |
163.4 | 170.6 | - | 172.5 | 160.8 | 141.8 | - | 149.7 | 135.6 | 89.7 | - | 149.7 | 38.2 | 50.6 | - | 105.5 | 101.6 | 80.7 | 90.5 | 123.3 | 76.8 | 105.1 | 83.1 | 122.1 | 98.3 | 86.5 | - | 101.6 | 115.0 | 114.3 | - | 106.5 | 38.0 | 46.2 | - | 112.4 | 41.2 | 32.8 | - | 67.9 | 24.4 | 36.5 | - | 33.2 | 13.6 | 23.3 | - | 97.1 | 25.8 | 403.8 | - | 85.8 | 55.8 | 164.9 | - |
All numbers in USD currency